Codes / ICD10CM / T59.3X2

T59.3X2 Toxic effect of lacrimogenic gas, intentional self-harm

ICD10CM code

ICD10CM

Name of the Condition

  • Toxic effect of lacrimogenic gas, intentional self-harm

Summary

This condition occurs when intentional self-harm involving lacrimogenic gas exposure results in harmful effects on the body. The toxic effects primarily target the eyes, respiratory system, and skin, with severity depending on the concentration and duration of exposure. Symptoms may range from mild irritation to severe respiratory distress, requiring medical evaluation and intervention.

Causes

Intentional self-harm is the primary cause, involving exposure to lacrimogenic gas (e.g., tear gas or pepper spray) as part of a deliberate act. Inhalation is the main route of exposure, though direct contact with the eyes or skin can also contribute to toxic effects. The agent may be deployed in a confined space or applied directly to increase absorption.

Risk Factors

  • History of self-harm behaviors or suicidal ideation
  • Access to lacrimogenic agents (e.g., personal defense products, law enforcement equipment)
  • Mental health conditions (e.g., depression, anxiety, or psychosis)
  • Lack of protective equipment during exposure
  • Pre-existing respiratory conditions (e.g., asthma, COPD) or eye sensitivities

Symptoms

  • Severe eye irritation, tearing, or blurred vision
  • Coughing, wheezing, or shortness of breath
  • Throat irritation or difficulty swallowing
  • Skin irritation or burns at the site of contact
  • Headache or dizziness
  • Respiratory distress or bronchospasm in severe cases

Diagnosis

Diagnosis involves assessing the history of intentional exposure and clinical symptoms. Physical examination focuses on the eyes, respiratory system, and skin. Laboratory tests may be performed to rule out other conditions, and imaging (e.g., chest X-rays) can evaluate respiratory involvement. Documentation of self-harm intent is critical for accurate coding.

Treatment Options

Treatment depends on symptom severity and may include:

  • Immediate removal from the exposure source and decontamination (e.g., flushing eyes/skin with water)
  • Supportive care (e.g., oxygen therapy for respiratory distress)
  • Medications (e.g., bronchodilators for wheezing, topical agents for eye/skin irritation)
  • Psychological evaluation and intervention for self-harm behaviors

Prognosis and Follow-Up

Prognosis varies based on exposure severity and underlying health. Mild cases typically resolve with decontamination and supportive care, while severe cases may require hospitalization. Follow-up includes monitoring for delayed respiratory or ocular complications and addressing mental health needs to prevent recurrence.

Complications

  • Persistent eye irritation or corneal damage
  • Chronic respiratory issues (e.g., bronchitis, asthma exacerbation)
  • Skin burns or scarring
  • Psychological sequelae (e.g., trauma, depression)

Lifestyle & Prevention

  • Secure storage of lacrimogenic agents to prevent access
  • Mental health support and crisis intervention for at-risk individuals
  • Education on safe handling and disposal of such agents
  • Use of protective equipment (e.g., masks, eye protection) in occupational settings

When to Seek Professional Help

Seek immediate medical attention if exposure causes:

  • Severe respiratory distress or difficulty breathing
  • Vision changes or eye pain
  • Skin burns or blistering
  • Signs of self-harm intent or suicidal thoughts

Tips for Medical Coders

Document the intentional self-harm context clearly, including exposure details and clinical findings. Ensure the code T59.3X2 is used for initial encounters related to this specific scenario. Verify that the intent (intentional self-harm) is distinct from accidental or undetermined exposure to avoid miscoding.